Neurological Surgery 脳神経外科50巻5号

2022年09月発行

特集 感染症—脳神経外科医のためのエッセンス Ⅲ脳神経外科と感染症—特殊な病態とトピックス

脳神経外科領域における新しい医療材料と感染症

著者： 小原亘太郎¹ 川俣貴一¹

所属機関： ¹東京女子医科大学脳神経外科

ページ範囲：P.1087 - P.1093

Point
・他家血液・組織由来の医療材料を使用する際には，感染のリスクを考慮する必要がある．
・創部感染を予防するために抗菌性を備えた医療材料が開発され，その有効性を検証するために多くの研究が行われている．

参考文献

1）Ahmed S, Darouiche RO：Anti-biofilm agents in control of device-related infections. Adv Exp Med Biol 831：137-146, 2015

2）Coello R, et al：Adverse impact of surgical site infections in English hospitals. J Hosp Infect 60：93-103, 2005

3）Hoshi K, et al：Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55：718-721, 2000

4）Young F：Skin graft fixation by plasma-thrombin adhesion. Ann Surg 120：450-459, 1944

5）Tidrick RT, Warner ED：Fibrin fixation of skin transplants. Surgery 15：90-95, 1944

6）Cronkite EP, et al：Use of thrombin and fibrinogen in skin grafting. JAMA 124：976-978, 1944

7）Eljamel MS, Foy PM：Acute traumatic CSF fistulae：the risk of intracranial infection. Br J Neurosurg 4：381-385, 1990

8）Ivan ME, et al：Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery. J Clin Neurosci 22：48-54, 2015

9）Qiu L, et al：Bioadhesives in neurosurgery：a review. J Neurosurg 15：1-11, 2019

10）Nakamura H, et al：The effect of autologous fibrin tissue adhesive on postoperative cerebrospinal fluid leak in spinal cord surgery：a randomized controlled trial. Spine（Phila Pa 1976）30：E347-E351, 2005

11）Albala DM, Lawson JH：Recent clinical and investigational applications of fibrin sealant in selected surgical specialties. J Am Coll Surg 202：685-697, 2006

12）Currie LJ, et al：The use of fibrin glue in skin grafts and tissue-engineered skin replacements：a review. Plast Reconstr Surg 108：1713-1726, 2001

13）Jain R, Wairkar S：Recent developments and clinical applications of surgical glues：an overview. Int J Biol Macromol 137：95-106, 2019

14）Rousou JA：Use of fibrin sealants in cardiovascular surgery：a systematic review. J Card Surg 28：238-247, 2013

15）Joch C：The safety of fibrin sealants. Cardiovasc Surg 11（Suppl 1）：23-28, 2003

16）Kawamura M, et al：Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 73：1098-1100, 2002

17）Dietrich W, et al：Aprotinin and anaphylaxis：analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 84：1144-1150, 2007

18）Kawamoto N, et al：Suspected fibrin glue-induced acute eosinophilic pneumonia after pulmonary resection：a case report. Thorac Cancer 12：2126-2129, 2021

19）Beierlein W, et al：An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 40：302-305, 2000

20）Saffarzadeh M, et al：Recalcitrant anaphylaxis associated with fibrin sealant：tTreatment with “TISSEEL-ectomy”. Plast Reconstr Surg Glob Open 9：e3382, 2021　doi：10.1097/GOX.0000000000003382

21）Orihara M, et al：Intraoperative anaphylaxis due to aprotinin after local application of fibrin sealant diagnosed by skin tests and basophil activation tests：a case report. JA Clin Rep 7：68, 2021　doi：10.1186/s40981-021-00472-6

22）Oswald AM, et al：Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 99：762-763, 2003

23）Kawashima M, et al：Feasibility of autologous fibrin glue in general thoracic surgery. J Thorac Dis 12：484-492, 2020

24）Nakayama N, et al：Efficacy, reliability, and safety of completely autologous fibrin glue in neurosurgical procedures：single-center retrospective large-number case study. World Neurosurg 109：e819-e828, 2018　doi：10.1016/j.wneu.2017.10.097

25）佐々木大雄，他：脊椎手術における全自己フィブリン糊の使用経験．J Spine Res 13：137-143, 2022

26）Narotam PK, et al：A clinicopathological study of collagen sponge as a dural graft in neurosurgery. J Neurosurg 82：406-412, 1995

27）Narotam PK, et al：Collagen matrix（DuraGen）in dural repair：analysis of a new modified technique. Spine（Plila Pa 1976）29：2861-2867；discussion 2868-2869, 2004

28）Haq I, et al：Postoperative fibrosis after surgical treatment of the porcine spinal cord：a comparison of dural substitutes. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2：50-54, 2005

29）Nakagawa S, et al：Postoperative infection after duraplasty with expanded polytetrafluoroethylene sheet. Neurol Med Chir（Tokyo）43：120-124；discussion 124, 2003

30）Sade B, et al：Non-watertight dural reconstruction in meningioma surgery：results in 439 consecutive patients and a review of the literature. Clinical article. J Neurosurg 114：714-718, 2011

31）Danish SF, et al：Experience with acellular human dura and bovine collagen matrix for duraplasty after posterior fossa decompression for Chiari malformations. J Neurosurg 104（1 Suppl）：16-20, 2006

32）Kshettry VR, et al：Evaluation of non-watertight dural reconstruction with collagen matrix onlay graft in posterior fossa surgery. J Korean Neurosurg Soc 59：52-57, 2016

33）McCall TD, et al：Use of resorbable collagen dural substitutes in the presence of cranial and spinal infections-report of 3 cases. Surg Neurol 70：92-96；discussion 96-97, 2008

34）Yasuhara T, Date I：Surgical site infection（SSI）in neurosurgery. No Shinkei Geka 49：1093-1104, 2021

35）Frantz VK：Absorbable cotton, paper and gauze：（oxidized cellulose）. Ann Surg 118：116-126, 1943

36）Dineen P：Antibacterial activity of oxidized regenerated cellulose. Surg Gynecol Obstet 142：481-486, 1976

37）Alfieri S, et al：Role of oxidized regenerated cellulose in preventing infections at the surgical site：prospective, randomized study in 98 patients affected by a dirty wound. Minerva chir 66：55-62, 2011

38）Momin M, et al：Recent advancements in cellulose-based biomaterials for management of infected wounds. Expert Opin Drug Deliv 18：1741-1760, 2021

39）Scher KS, Coil JA Jr：Effects of oxidized cellulose and microfibrillar collagen on infection. Surgery 91：301-304, 1982

, increases the cell death of neuronal and glial cells in vitro. Materials（Basel）13：2453, 2020　doi：10.3390/ma13112453

41）Tomizawa Y, et al：In vitro and in vivo evaluation of the biocompatibility and cytotoxicity of local hemostatic agents. Jpn J Thoracic Cardiovasc Surg 33：382-386, 2004

42）Dutton JJ, et al：Compressive optic neuropathy following use of intracranial oxidized cellulose hemostat. Ophthalmic Surg 14：487-490, 1983

43）Sugar O：Oxidized cellulose hemostat（surgicel）. Surg Neurol 21：521, 1984

44）Bakhsheshian J, et al：The use of vancomycin powder in modern spine surgery：systematic review and meta-analysis of the clinical evidence. World neurosurg 83：816-823, 2015

45）Dodson V, et al：The effect of prophylactic vancomycin powder on infections following spinal surgeries：a systematic review. Neurosurg Focus 46：E11, 2019

46）Katz S, et al：Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 194：35-41, 1981

47）Merritt K, et al：Tissue colonization from implantable biomaterials with low numbers of bacteria. J Biomed Mater Res 44：261-265, 1999

48）Onesti MG, et al：Effectiveness of antimicrobial-coated sutures for the prevention of surgical site infection：a review of the literature. Eur Rev Med Pharmacol Sci 22：5729-5739, 2018

plus antibacterial suture（coated polyglactin 910 with triclosan）using zone of inhibition assays. Surg Infect（Larchmt）3（Suppl 1）：S79-S87, 2002

50）Storch ML, et al：Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect（Larchmt）5：281-288, 2004

51）Marzo G, et al：In vitro antibacterial efficacy of Vicryl plus suture（coated polyglactin 910 with triclosan）using zone of inibition assays. Oral Implantol（Rome）1：43-48, 2008

52）Edmiston CE, et al：Bacterial adherence to surgical sutures：can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203：481-489, 2006

53）Ming X, et al：In vivo and in vitro antibacterial efficacy of PDS plus（polidioxanone with triclosan）suture. Surg Infect（Larchmt）9：451-457, 2008

54）Ming X, et al：In vitro antibacterial efficacy of MONOCRYL plus antibacterial suture（poliglecaprone 25 with triclosan）. Surg Infect（Larchmt）8：201-208, 2007

55）Ming X, et al：In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture（poliglecaprone 25 with triclosan）. Surg Infect（Larchmt）8：209-214, 207

56）Galal I, El-Hindawy K：Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. Am J Surg 202：133-138, 2011

Plus）suture for closure of the abdominal wall after colorectal surgery. Coll Antropol 35：439-443, 2011

58）Nakamura T, et al：Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery：a randomized controlled trial. Surgery 153：576-583, 2013

59）Justinger C, et al：Surgical-site infection after abdominal wall closure with triclosan-impregnated polydioxanone sutures：results of a randomized clinical pathway facilitated trial（NCT00998907）. Surgery 154：589-595, 2013

60）Thimour-Bergström L, et al：Triclosan-coated sutures reduce surgical site infection after open vein harvesting in coronary artery bypass grafting patients：a randomized controlled trial. Eur J Cardiothorac Surg 44：931-938, 2013

61）Rozzelle CJ, et al：Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery：a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2：111-117, 2008

）：a prospective, single-blind, randomized controlled trial. BMC Surg 18：45, 2018

63）Ford HR, et al：Intraoperative handling and wound healing：controlled clinical trial comparing coated VICRYL plus antibacterial suture（coated polyglactin 910 suture with triclosan）with coated VICRYL suture（coated polyglactin 910 suture）. Surg Infect（Larchmt）6：313-321, 2005

64）Mingmalairak C, et al：Efficacy of antimicrobial coating suture coated polyglactin 910 with tricosan（Vicryl plus）compared with polyglactin 910（Vicryl）in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. J Med Assoc Thai 92：770-775, 2009

65）Sprowson AP, et al：The effect of triclosan-coated sutures on the rate of surgical site infection after hip and knee arthroplasty：a double-blind randomized controlled trial of 2546 patients. Bone Joint J 100-B：296-302, 2018

66）Diener MK, et al：Effectiveness of triclosan-coated PDS Plus versus uncoated PDS Ⅱ sutures for prevention of surgical site infection after abdominal wall closure：the randomised controlled PROUD trial. Lancet 384：142-152, 2014

67）Williams N, et al：Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. Surg Infect（Larchmt）12：469-474, 2011

68）Baracs J, et al：Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture（PDS Plus）vs. uncoated sutures（PDS Ⅱ）：a randomized multicenter study. Surg Infect（Larchmt）12：483-489, 2011

69）Turtiainen J, et al：Effect of triclosan-coated sutures on the incidence of surgical wound infection after lower limb revascularization surgery：a randomized controlled trial. World J Surg 36：2528-2534, 2012

70）Ichida K, et al：Effect of triclosan-coated sutures on the incidence of surgical site infection after abdominal wall closure in gastroenterological surgery：a double-blind, randomized controlled trial in a single center. Surgery 164：91-95, 2018

71）Wu X, et al：Antimicrobial-coated sutures to decrease surgical site infections：a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 36：19-32, 2017

72）Apisarnthanarak A, et al：Triclosan-coated sutures reduce the risk of surgical site infections：a systematic review and meta-analysis. Infect Control Hosp Epidemiol 36：169-179, 2015

73）Ahmed I, et al：The use of triclosan-coated sutures to prevent surgical site infections：a systematic review and meta-analysis of the literature. BMJ Open 9：e029727, 2019　doi：10.1136/bmjopen-2019-029727

74）Wang ZX, et al：Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg 100：465-473, 2013

75）Chang WK, et al：Triclosan-impregnated sutures to decrease surgical site infections：systematic review and meta-analysis of randomized trials. Ann Surg 255：854-859, 2012

76）Sandini M, et al：Systematic review and meta-analysis of sutures coated with triclosan for the prevention of surgical site infection after elective colorectal surgery according to the PRISMA statement. Medicine（Baltimore）95：e4057, 2016　doi：10.1097/MD.0000000000004057

77）World Health Organization（WHO）：Global Guidelines for the Prevention of Surgical site Infection, 2nd ed. 2018

78）Berríos-Torres SI, et al；Healthcare Infection Control Practices Advisory Committee：Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152：784-791, 2017

79）日本外科感染症学会（編）：消化器外科SSI予防のための周術期管理ガイドライン2018．診断と治療社，東京，2018

80）Anderson DJ, et al：Strategies to prevent surgical site infections in acute care hospitals：2014 update. Infect Control Hosp Epidemiol 35：605-627, 2014

81）National Institute for Health and Care Excellence：Clinical Guidelines. Surgical site infections：prevention and treatment. National Institute for Health and Care Excellence（NICE）, London, 2020

82）Ueno M, et al：Triclosan-coated sutures reduce wound infections after spinal surgery：a retrospective, nonrandomized, clinical study. Spine J 15：933-938, 2015

83）Matl FD, et al：New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids. J Biomater Sci Polym Ed 20：1439-1449, 2009

84）Obermeier A, et al：Novel high efficient coatings for anti-microbial surgical sutures using chlorhexidine in fatty acid slow-release carrier systems. PLoS One 9：e101426, 2014　doi：10.1371/journal.pone.0101426

85）Obermeier A, et al：Viable adhered Staphylococcus aureus highly reduced on novel antimicrobial sutures using chlorhexidine and octenidine to avoid surgical site infection（SSI）. PLoS One 13：e0190912, 2018　doi：10.1371/journal.pone.0190912